ELDON BIOLOGICALS A/S: Financial statements 2023
CVR: 26747007
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 12,307,390 and a net result of DKK 5,362,663 compared with DKK 4,971,816 the year before. That is a decrease of 24.9% compared with the year before. Equity in the 2023 report amounted to DKK 34,481,953. The solvency ratio was 87.1%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 12,307,390
- Profit/Loss
- DKK 5,362,663
- Equity
- DKK 34,481,953
- Total Assets
- DKK 39,587,627
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 12.3 mio. | 5.4 mio. | 34.5 mio. | 10 |
| 2022 | - | 16.4 mio. | 5 mio. | 29.6 mio. | 9 |
| 2021 | - | 19.5 mio. | 9.1 mio. | 25.1 mio. | 11 |
| 2020 | - | 14.3 mio. | 6.6 mio. | 16.5 mio. | 8 |
| 2019 | - | 9.5 mio. | 3.3 mio. | 10.5 mio. | 6 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The board consists of Michael Lützhøft Hansen (chair), Cara Beth Seiderman and Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity in the 2025 report amounted to DKK 42,055,949.